Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial resultsKelly C. Goldsmith, Yaël P. Mossé, Fariba Goodarzian et al.|Nature Medicine|2023Cited by 125
Use of Point-of-Care Ultrasonography in the NICU for Diagnostic and Procedural PurposesDan L. Stewart, Laura Laskosz, Patricia T. Acharya et al.|PEDIATRICS|2022Cited by 76